Physician profile
James Michael Grimes
NPI 1750412607
$1,697.69
in general payments reported to CMS, 2019-2025
9 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $642 · 2023: $560 · 2024: $148 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $723.05 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Epic, Aveir |
| Atricure, INC. | $606.54 | 2021-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Cvrx, INC. | $147.34 | 2021-2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $96.27 | 2021-2023 | |
| Medtronic, INC. | $55.41 | 2021 | |
| Abbvie INC. | $28.55 | 2022 | |
| Novo Nordisk INC | $13.91 | 2022 | |
| Ethicon US, LLC | $13.66 | 2022 | |
| Kci USA, INC. | $12.96 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Grimes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.